{"Leuprolide":{"RelatedTo":"Gonadotropin-releasing hormone receptor","Synonym":["Eligard","inhalable","leuprolide"],"SuperCategory":"Molecular entity","Comment":"taken from DrugBank","Id":"DB00007","Curator":"ab","Has role":"Drug","DefiningCitation":"http:\/\/www.drugbank.ca\/drugs\/DB00007","Definition":"Synthetic 9 residue peptide analog of gonadotropin releasing hormone. Pharmacology: Used in the palliative treatment of advanced prostate cancer. Leuprolide is a luteinizing hormone agonist that results in suppression of testicular or follicular steroidogenesis. Mechanism of action: Leuprolide binds to the gonadotropin releasing hormone receptor and acts as a potent inhibitor of gonadotropin secretion. Drug type: Approved. Biotech. Investigational. Drug category: Anti-Estrogen Agents. Antineoplastic Agents"}}